1. Home
  2. SRRK vs OR Comparison

SRRK vs OR Comparison

Compare SRRK & OR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRRK
  • OR
  • Stock Information
  • Founded
  • SRRK 2012
  • OR 2014
  • Country
  • SRRK United States
  • OR Canada
  • Employees
  • SRRK N/A
  • OR N/A
  • Industry
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • OR Precious Metals
  • Sector
  • SRRK Health Care
  • OR Basic Materials
  • Exchange
  • SRRK Nasdaq
  • OR Nasdaq
  • Market Cap
  • SRRK 3.1B
  • OR 3.7B
  • IPO Year
  • SRRK 2018
  • OR N/A
  • Fundamental
  • Price
  • SRRK $30.67
  • OR $24.32
  • Analyst Decision
  • SRRK Strong Buy
  • OR Strong Buy
  • Analyst Count
  • SRRK 6
  • OR 3
  • Target Price
  • SRRK $42.17
  • OR $23.00
  • AVG Volume (30 Days)
  • SRRK 1.3M
  • OR 878.3K
  • Earning Date
  • SRRK 05-14-2025
  • OR 05-07-2025
  • Dividend Yield
  • SRRK N/A
  • OR 0.77%
  • EPS Growth
  • SRRK N/A
  • OR N/A
  • EPS
  • SRRK N/A
  • OR 0.17
  • Revenue
  • SRRK N/A
  • OR $201,026,000.00
  • Revenue This Year
  • SRRK N/A
  • OR $59.15
  • Revenue Next Year
  • SRRK $601.05
  • OR $6.36
  • P/E Ratio
  • SRRK N/A
  • OR $146.59
  • Revenue Growth
  • SRRK N/A
  • OR 9.09
  • 52 Week Low
  • SRRK $6.76
  • OR $15.12
  • 52 Week High
  • SRRK $46.98
  • OR $24.18
  • Technical
  • Relative Strength Index (RSI)
  • SRRK 47.15
  • OR 64.53
  • Support Level
  • SRRK $28.76
  • OR $23.03
  • Resistance Level
  • SRRK $33.48
  • OR $24.70
  • Average True Range (ATR)
  • SRRK 1.71
  • OR 0.70
  • MACD
  • SRRK -0.04
  • OR -0.04
  • Stochastic Oscillator
  • SRRK 32.60
  • OR 85.31

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

About OR Osisko Gold Royalties Ltd

Osisko Gold Royalties Ltd is engaged in the business of acquiring and managing precious metal and other high-quality royalties, streams and similar interests. The Company owns a portfolio of royalties, streams, offtakes, options on royalty/stream financings and exclusive rights to participate in future royalty/stream financings on various projects. Geographically, it generates majority of its income from North America and also generates some portions of income from South America, Australia, Africa and Europe.

Share on Social Networks: